Life Science Industry Updates


  • All
  • Manufacturing
  • Marketing
  • Biotech
  • All

    Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline

    Worth the read. BioPharma Dive

    Takeda takes full control of drug for rare epilepsies

    Let us know what you think about this. BioPharma Dive

    CureVac, Novartis team up in latest pandemic vaccine manufacturing collaboration

    Stay connected to what’s happening in Life Sciences. Fierce Pharma

    Novavax was on its last leg pre-COVID. With a promising shot on deck, it's now eyeing a big 2021

    Did you know about this? Fierce Pharma

    Bluebird Bio hits pause on rollout for ill-fated gene therapy Zynteglo as trial flags 2 cancer cases

    So relevant. Fierce Pharma

    Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

    Have you read this yet? Fierce Pharma

    Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture

    You heard it from SOURCE EXPLORER. Fierce Biotech

    GSK, Vir hit as COVID-19 drug hopeful halted on possible weak efficacy in key NIH phase 3

    Straight from the SOURCE. Fierce Biotech

    Sponsored Ad

    Featured

    Sponsored Ad

    Vir shares tumble after apparent setback for COVID-19 drug

    Who do you know who’d find this relevant? BioPharma Dive

    Lilly drug regrows hair in autoimmune disease study, but safety questions linger

    Share with a colleague. BioPharma Dive

    Biogen cements gene therapy ambitions with $200M factory in Research Triangle

    Life Science news you need to know. Fierce Pharma

    CDMO Celonic to beef up cell and gene therapy work at up-and-coming Novartis hub

    Expert thoughts. Fierce Pharma

    Moderna has sewn up $18 billion in COVID-19 vaccine orders—and it's negotiating more

    Share with your team. Fierce Pharma

    ASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data

    This is what’s on our minds. Fierce Pharma

    BlackRock powers Exscientia to $100M series C round to fund autonomous drug design

    You’ll want to read this between meetings. Fierce Biotech

    Biden still pushing for his cancer 'breakthrough' dream, but can it work?

    What do you think? Fierce Biotech

    SOURCE EXPLORER Updates

    Does the Pharmaceutical Industry Need Mark Cuban’s Disruption?

    Does the Pharmaceutical Industry Need Mark Cuban’s Disruption?

    Sponsored Ad

    MY WIFE GOT COVID-19. I GOT THE VACCINE.

    MY WIFE GOT COVID-19. I GOT THE VACCINE.

    How Has COVID Impacted Gender Equality?

    How Has COVID Impacted Gender Equality?

    Why Less is More — Nootropics and Microdosing

    Why Less is More — Nootropics and Microdosing

    OK, We’ve Just Realized That WFH Has Made Us All More Human

    OK, We’ve Just Realized That WFH Has Made Us All More Human

    View all Updates